Uhlyar, Stepan <br/><br/>
Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive Dyskinesia.  [electronic resource] 

 -  P & T : a peer-reviewed journal for formulary management  Jun 2018 
 - 328-331 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1052-1372